Threshold Pharmaceuticals THLD

Name: Threshold Pharmaceuticals THLD
Uploaded: 2012-02-04
Duration: 1 min 35 s
Description: CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold?s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012.

karmastock Follow 2

Date: 2012. 02. 04.

Shares: 0 Forwards: 0 Embeds: 1

Category: people & vlogs

Add to list

To Quicklist To Favorites

Embed video

Width

Height

Embed code:

<iframe width="640" height="360" src="//videa.hu/player?v=yXWRV9UQ9avlLLYu" allowfullscreen="allowfullscreen" webkitallowfullscreen="webkitallowfullscreen" mozallowfullscreen="mozallowfullscreen" frameborder="0"></iframe>

Create GIF

Time:

99:99 sec

Resolution:

Crop: Custom 16:9 4:3 Original

Speed (fps): 2 10 20

Create snapshot

New snapshot Download (png) Download (jpg)

Report video

Reason for rejection:

Please provide the following details precisely:

A teljes hivatalos nevedet, amely általában családnévből és utónévből áll, egy államilag kibocsátott személyazonosító igazolvánnyal megegyezően. A Videa addig nem tudja feldolgozni a kérelmet, amíg nem rendelkezik ezzel az információval.

A jogosult lakcímét/székhelyét, telefonszámát és email címét.

Add meg a sérelem tárgyát, és a jogsértést valószínűsítő tények megjelölését.

A kérelem ellenőrzését követően a Videa elindítja a videó eltávolításának folyamatát.

REPORT

Date: 2012. 02. 04.

Shares: 0

Forwards: 0

Embeds: 1

Tags: merck • nasdaq:thld • thld • threshold • threshold pharmaceuticals

Category: people & vlogs

CRWENewswire, Stocks to Watch. Threshold Pharmaceuticals Inc - THLD - reported that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold?s small molecule hypoxia-targeted drug. Threshold will receive an upfront payment of $25 million and could receive up to $35 million in additional development milestones during 2012.